Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.348, 2002-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The HAART of the matter: cutting the cost of Lazarus syndrome
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Access to resources
Recommend
HAART introduction in Italy provides cost, QOL advantage
Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. :
HAART introduction in Italy provides cost, QOL advantage
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. :
HAART: Neurological immune reconstitution syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1179, 2007-01 ,pp. :
Pioglitazone improves HAART-induced metabolic syndrome
Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. :